Beyond Dopamine: Cannabidiol in Parkinson's C...

In this episode, we focus on the challenges faced in metabolic monitoring of youth receiving second-generation antipsychotics (SGAs), including the strategies to overcome these barriers and ensure the long-term health of young patients on SGAs. Faculty: David Rosenberg, M.D. Host ...  Show more

In this episode, we delve into the potential outcomes after the first SSRI trial for OCD. With SSRIs being a first-line treatment, understanding response patterns is crucial. What course of action should be taken when patients exhibit significant symptom improvement, partial reli ...  Show more

In this week's episode, Brain & Life Podcast co-host Dr. Katy Peters is joined by Annmarie O'Connor, a Parkinson's disease advocate, bestselling author, and fashion editor. Annmarie shares her personal journey with early-onset Parkinson's, discussing the challenges and insights s ...  Show more

The neuroscience behind the benefits and risks of marijuana, explained.

Splintered legislature, evolving taboos, and new forms of consumption have created a fragmented market for cannabis, and made it challenging for scientists to research its effects on our brains and ...

Dr. Jeff Ratliff talks with Dr. Raúl Martínez-Fernández about the long-term outcome of unilateral FUS-STN treatment for Parkinson disease.

Read the related article in Neurology</ ...

Many people will be familiar with Parkinson’s disease: the progressive brain disorder that causes symptoms including tremors and slower movement, leading on to serious cognitive problems. You might not know that it’s the fastest-growing neurological condition in the world. Today ...  Show more